Last reviewed · How we verify
NCT03405987
Association of T1-mapping and LV Strain Analysis by CMR
trial testing Strain analysis by CMR in Myocardial Fibrosis in 300 participants. Status unknown.
1 December 2020
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 July 2012 |
| Primary completion | 1 December 2020 |
| Estimated completion | 1 December 2020 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Strain analysis by CMR
Conditions studied
- Myocardial Fibrosis — all drugs for Myocardial Fibrosis →
Sponsor
Medical University of Vienna
Who can join
18 and older, any sex, with Myocardial Fibrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The association of T1-mapping (both native and ECV) and strain analysis of LV and RV by CMR will be assessed. Results from strain analysis will be investigated in terms of their prognostic value.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feature Tracking of Global Longitudinal Strain by Using Cardiovascular MRI Improves Risk Stratification in Heart Failure with Preserved Ejection Fraction.
Kammerlander AA, Donà C, Nitsche C, Koschutnik M, et al · · 2020 · cited 54× · PMID 32484413 · DOI 10.1148/radiol.2020200195
Verify or expand the search:
- PubMed search for NCT03405987
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Fibrosis
Currently open trials in the same condition.
- NCT07296081 — ⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure · recruiting
- NCT06994221 — Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm · recruiting
- NCT05912231 — Ultrahypofractionation and Normal Tissue Toxicity · NA · active not recruiting
- NCT05302271 — Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia · Phase 1 · recruiting
- NCT06619600 — Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardi · Phase 3 · active not recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03405987 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 16 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03405987.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing